In short
Disodium Levofolinate, also known as Sodium Levofolinate or Levoleucovorin Disodium, is a medication being studied in clinical trials for various types of cancer. This article explores its use in combination with other drugs for treating conditions such as metastatic esophageal cancer, colon cancer, and pancreatic cancer. We'll examine how researchers are investigating its potential to improve treatment outcomes and patient quality of life.
What is Disodium Levofolinate?
Disodium Levofolinate, also known as Sodium Levofolinate or Levoleucovorin Disodium, is a medication used in cancer treatment. It belongs to a class of drugs called folic acid analogues, which are substances that mimic the action of folic acid in the body.
Medical Uses
Disodium Levofolinate is primarily used in the treatment of various types of cancer, including:
- Colorectal cancer: Particularly in stage II and III colon cancer
- Pancreatic cancer: Specifically in metastatic pancreatic ductal adenocarcinoma
- Esophageal cancer: Used in combination with other chemotherapy drugs for metastatic esophageal carcinoma
How It Works
Disodium Levofolinate works by enhancing the effects of certain chemotherapy drugs, particularly 5-fluorouracil (5-FU). It helps to increase the effectiveness of these drugs in killing cancer cells while potentially reducing some of their side effects.
Administration
Disodium Levofolinate is typically administered through intravenous infusion. The dosage and frequency of administration can vary depending on the specific cancer type and treatment regimen. In some clinical trials, it has been used at doses up to 200 mg/m² (milligrams per square meter of body surface area).
Current Clinical Trials
Several ongoing clinical trials are investigating the use of Disodium Levofolinate in combination with other cancer treatments:
- A study for patients with metastatic esophageal carcinoma, combining Disodium Levofolinate with pembrolizumab, lenvatinib, and chemotherapy.
- A trial for patients with stage III and high-risk stage II colon cancer, using a personalized approach based on blood and tumor characteristics.
- A study for patients with metastatic pancreatic ductal adenocarcinoma, combining Disodium Levofolinate with mitazalimab and chemotherapy.
Potential Side Effects
While specific side effects of Disodium Levofolinate are not detailed in the provided information, patients should be aware that all medications can cause side effects. Common side effects associated with cancer treatments may include:
- Nausea and vomiting
- Fatigue
- Changes in blood cell counts
- Diarrhea
It's important to discuss potential side effects with your healthcare provider.
Precautions and Contraindications
Patients should inform their healthcare provider about any existing medical conditions or medications they are taking. Some precautions and contraindications may include:
- Known DPD (DihydroPyrimidine Dehydrogenase) deficiency
- Pregnancy or breastfeeding
- History of certain autoimmune diseases or immunodeficiencies
- Liver or kidney problems
Always consult with your healthcare provider for personalized advice and information about Disodium Levofolinate and its use in your specific treatment plan.